Evidence map›Paper›PMID 27911100›Full record

ReviewExpert review of hematology2017

Mitochondria and Iron: current questions.

Bibbin T Paul, David H Manz, Frank M Torti, Suzy V Torti

Erratum issued Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Expert review of hematology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07084298 (Effects of 12 Weeks of Oral Iron Supplementation on Skeletal Muscle Iron Content, Mitochondrial Function, and Indices of Aerobic Fitness in Healthy Females With Suboptimal Iron Stores), which is not on this map. Cited by 252 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
252citing papers in PubMed, 1 pooled it
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07084298 early_phase1not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Effects of 12 Weeks of Oral Iron Supplementation on Skeletal Muscle Iron Content, Mitochondrial Function, and Indices of Aerobic Fitness in Healthy Females With Suboptimal Iron Stores

TypeinterventionalSponsorUniversity of CalgaryRan2025 to 2026Enrolled36ConditionsIron DeficiencyArmsOral iron supplement, Placebo
3 · Its place in the literature

Who cites it

252 citing papers in PubMed, 1 synthesis or guideline pooled it, 423 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. METTL18 is Required for Developmental, Metabolic, and Endocrine Regulation of Mammalian Growth.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Iron Dysregulation and Vascular Diseases: A Contemporary Review.Journal of the American Heart Association · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

192 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Bibbin T Paula Department of Molecular Biology and Biophysics , University of Connecticut Health , Farmington , CA , USA.
David H Manza Department of Molecular Biology and Biophysics , University of Connecticut Health , Farmington , CA , USA.
Frank M Tortic Department of Medicine , University of Connecticut Health , Farmington , CT , USA .
Suzy V Tortia Department of Molecular Biology and Biophysics , University of Connecticut Health , Farmington , CA , USA.
UConn Health · US

Funding

Skeletal, Craniofacial and Oral Biology Training GrantT90DE021989 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MINA, MINA · 2011 to 2022
$4.5M
Iron, Ferroptosis and Ovarian CancerR01CA188025 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI TORTI, SUZY V · 2014 to 2024
$3.9M
Ferroportin and Iron HomeostasisR01CA171101 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI TORTI, FRANK M. · 2012 to 2016
$1.7M
Skeletal, Craniofacial and Oral Biology Training GrantR90DE022526 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MINA, MINA · 2011 to 2022
$627k
Role of Ferroportin in reducing Prostate Cancer MetastasisF30DE026380 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MANZ, DAVID H · 2016 to 2021
$207k
NCI NIH HHS R01 CA171101NCI NIH HHS R01 CA188025NIDCR NIH HHS F30 DE026380NIDCR NIH HHS R90 DE022526NIDCR NIH HHS T90 DE021989
6 · The paper itself

Abstract

introductionMitochondria are cellular organelles that perform numerous bioenergetic, biosynthetic, and regulatory functions and play a central role in iron metabolism. Extracellular iron is taken up by cells and transported to the mitochondria, where it is utilized for synthesis of cofactors essential to the function of enzymes involved in oxidation-reduction reactions, DNA synthesis and repair, and a variety of other cellular processes. Areas covered: This article reviews the trafficking of iron to the mitochondria and normal mitochondrial iron metabolism, including heme synthesis and iron-sulfur cluster biogenesis. Much of our understanding of mitochondrial iron metabolism has been revealed by pathologies that disrupt normal iron metabolism. These conditions affect not only iron metabolism but mitochondrial function and systemic health. Therefore, this article also discusses these pathologies, including conditions of systemic and mitochondrial iron dysregulation as well as cancer. Literature covering these areas was identified via PubMed searches using keywords: Iron, mitochondria, Heme Synthesis, Iron-sulfur Cluster, and Cancer. References cited by publications retrieved using this search strategy were also consulted. Expert commentary: While much has been learned about mitochondrial and its iron, key questions remain. Developing a better understanding of mitochondrial iron and its regulation will be paramount in developing therapies for syndromes that affect mitochondrial iron.

Indexed as

AnimalsBiological TransportCarrier ProteinsDisease SusceptibilityHemeHumansIronMitochondriaNeoplasmsProtein BindingSulfurCarrier ProteinsHemeIronSulfurcancerheme synthesisIroniron-sulfur clusteriron traffickingmitochondria

Identifiers

PMID27911100
PMCPMC5538026
OpenAlexW2559410759

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.